Skip to main content

Main menu

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Instructions for authors
  • About the journal
    • About the journal
    • Editorial board
    • Instructions for authors
    • FAQs
    • Chinese Stroke Association
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
  • BMJ Journals

User menu

  • Login

Search

  • Advanced search
  • BMJ Journals
  • Login
  • Facebook
  • Twitter
Stroke and Vascular Neurology

Advanced Search

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Instructions for authors
  • About the journal
    • About the journal
    • Editorial board
    • Instructions for authors
    • FAQs
    • Chinese Stroke Association
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
Open Access

Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China

Zixiao Li, Xinmiao Zhang, Lingling Ding, Jing Jing, Hong-Qiu Gu, Yong Jiang, Xia Meng, Chunying Du, Chunjuan Wang, Meng Wang, Man Xu, Yanxu Zhang, Meera Hu, Hao Li, Xiping Gong, Kehui Dong, Xingquan Zhao, Yilong Wang, Liping Liu, Ying Xian, Eric Peterson, Gregg C Fonarow, Lee H Schwamm, Yongjun Wang
DOI: 10.1136/svn-2023-002411 Published 12 September 2023
Zixiao Li
1Department of Neurology, Beijing Tiantan Hospital, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
3Chinese Institute for Brain Research, Beijing, China
4Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zixiao Li
Xinmiao Zhang
1Department of Neurology, Beijing Tiantan Hospital, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xinmiao Zhang
Lingling Ding
1Department of Neurology, Beijing Tiantan Hospital, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lingling Ding
Jing Jing
1Department of Neurology, Beijing Tiantan Hospital, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jing Jing
Hong-Qiu Gu
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hong-Qiu Gu
Yong Jiang
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xia Meng
1Department of Neurology, Beijing Tiantan Hospital, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chunying Du
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chunjuan Wang
1Department of Neurology, Beijing Tiantan Hospital, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meng Wang
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Meng Wang
Man Xu
5Hanalytics Artificial Intelligence Research Centre for Neurological Disorders, China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanxu Zhang
5Hanalytics Artificial Intelligence Research Centre for Neurological Disorders, China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meera Hu
5Hanalytics Artificial Intelligence Research Centre for Neurological Disorders, China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hao Li
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hao Li
Xiping Gong
1Department of Neurology, Beijing Tiantan Hospital, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kehui Dong
1Department of Neurology, Beijing Tiantan Hospital, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xingquan Zhao
1Department of Neurology, Beijing Tiantan Hospital, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
4Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xingquan Zhao
Yilong Wang
1Department of Neurology, Beijing Tiantan Hospital, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yilong Wang
Liping Liu
1Department of Neurology, Beijing Tiantan Hospital, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Liping Liu
Ying Xian
6Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Peterson
7Division of Cardiology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregg C Fonarow
8Cardiology, Ronald Reagan UCLA Medical Center, Los Angeles, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lee H Schwamm
9Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yongjun Wang
1Department of Neurology, Beijing Tiantan Hospital, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
4Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, China
10Clinical Center for Precision Medicine in Stroke, Capital Medical Universit, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yongjun Wang
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Supplementary Materials
  • Additional Files
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    The flow chart of this study. AI-CDSS, artificial intelligence-based clinical decision support system.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    The framework for cerebrovascular disease clinical decision support system (CDSS). EMR, Electronic Medical Record; HIS, Hospital Information System; LIS, Laboratory Information Management System; PACS, Picture Archiving and Communication System; TOAST, Trial of Org 10172 in Acute Stroke Treatment; CISS, Chinese Ischemic Stroke Subclassification.

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    Intervention flow chart. CDSS, clinical decision support system.

Tables

  • Figures
  • Supplementary Materials
  • Additional Files
  • Table 1

    The inclusion and exclusion criteria for the hospitals

    Inclusion criteriaExclusion criteria
    1. Tertiary-grade or secondary-grade hospitals1. Primary-grade (ie, community) hospitals
    2. Consisting of emergency department and neurological wards for patients who had a stroke2. <20 patients who had an acute ischaemic stroke admitted per month
    3. Consisting of 1.5T or 3T MRI machine with the functionalities for completing DWI and MRA scan3. Specialised hospitals (cancer hospitals, maternity hospitals, children’s hospitals, etc)
    • DWI, diffusion weighted imaging.

  • Table 2

    The inclusion and exclusion criteria for the participants

    Inclusion criteriaExclusion criteria
    1. Older than 18 years1. Negative ischaemic stroke on DWI or transient ischaemic attack
    2. Ischaemic stroke within 7 days of symptom onset2. Diagnosis of other cerebrovascular diseases (cerebral haemorrhage, subarachnoid haemorrhage, cerebral venous sinus thrombosis, etc)
    3. Ischaemic stroke confirmed by imaging of the brain3. Diagnosis of other diseases (epilepsy, central nervous system infection, metabolic encephalopathy, etc)
    4. Hospitalisation from emergency or outpatient department4. Pregnancy or delivery within the 6 weeks before the study
    5. Participants or their legal guardians give their permission to conduct the study by signing an informed consent5. Participation in other pharmaceutical or device-based interventional studies
    6. With terminal diseases (life expectancy<3 months) or cannot commit to completing the study due to other reasons
    • DWI, diffusion weighted imaging.

Supplementary Materials

  • Figures
  • Tables
  • Additional Files
  • Supplementary data

    [svn-2023-002411supp001.pdf]

Additional Files

  • Figures
  • Tables
  • Supplementary Materials
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    • Data supplement 1
PreviousNext
Back to top
Vol 10 Issue 1 Table of Contents
Stroke and Vascular Neurology: 10 (1)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Email

Thank you for your interest in spreading the word on Stroke and Vascular Neurology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China
(Your Name) has sent you a message from Stroke and Vascular Neurology
(Your Name) thought you would like to see the Stroke and Vascular Neurology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China
Zixiao Li, Xinmiao Zhang, Lingling Ding, Jing Jing, Hong-Qiu Gu, Yong Jiang, Xia Meng, Chunying Du, Chunjuan Wang, Meng Wang, Man Xu, Yanxu Zhang, Meera Hu, Hao Li, Xiping Gong, Kehui Dong, Xingquan Zhao, Yilong Wang, Liping Liu, Ying Xian, Eric Peterson, Gregg C Fonarow, Lee H Schwamm, Yongjun Wang
Stroke and Vascular Neurology Sep 2023, svn-2023-002411; DOI: 10.1136/svn-2023-002411

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Cite This
  • APA
  • Chicago
  • Endnote
  • MLA
Loading
Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China
Zixiao Li, Xinmiao Zhang, Lingling Ding, Jing Jing, Hong-Qiu Gu, Yong Jiang, Xia Meng, Chunying Du, Chunjuan Wang, Meng Wang, Man Xu, Yanxu Zhang, Meera Hu, Hao Li, Xiping Gong, Kehui Dong, Xingquan Zhao, Yilong Wang, Liping Liu, Ying Xian, Eric Peterson, Gregg C Fonarow, Lee H Schwamm, Yongjun Wang
Stroke and Vascular Neurology Sep 2023, svn-2023-002411; DOI: 10.1136/svn-2023-002411
Download PDF

Share
Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China
Zixiao Li, Xinmiao Zhang, Lingling Ding, Jing Jing, Hong-Qiu Gu, Yong Jiang, Xia Meng, Chunying Du, Chunjuan Wang, Meng Wang, Man Xu, Yanxu Zhang, Meera Hu, Hao Li, Xiping Gong, Kehui Dong, Xingquan Zhao, Yilong Wang, Liping Liu, Ying Xian, Eric Peterson, Gregg C Fonarow, Lee H Schwamm, Yongjun Wang
Stroke and Vascular Neurology Sep 2023, svn-2023-002411; DOI: 10.1136/svn-2023-002411
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Article
    • Abstract
    • Introduction
    • Methods
    • Discussion
    • Data availability statement
    • Ethics statements
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Rationale and Study Design to Assess the Efficacy and Safety of Minocycline in Patients with Moderate to Severe Acute Ischaemic Stroke (EMPHASIS)
  • Role of histone deacetylases and sirtuins in the ischaemic stroke: a protocol for a systematic review and meta-analysis of animal studies
  • Efficacy and safety of Ferrous iron on the prevention of Vascular cOgnitive impaiRment among patients with cerebral Infarction/TIA (FAVORITE): rationale and design of a multicentre randomised trial
Show more Protocol

Similar Articles

 
 

CONTENT

  • Latest content
  • Current issue
  • Archive
  • eLetters
  • Sign up for email alerts
  • RSS

JOURNAL

  • About the journal
  • Editorial board
  • Recommend to librarian
  • Chinese Stroke Association

AUTHORS

  • Instructions for authors
  • Submit a paper
  • Track your article
  • Open Access at BMJ

HELP

  • Contact us
  • Reprints
  • Permissions
  • Advertising
  • Feedback form

© 2025 Chinese Stroke Association